New Zealand Pharmaceuticals & Biotech High Insider Buying

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

2 companies

Pacific Edge

Market Cap: NZ$329.1m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.27

-1.9%

152.4%

Rua Bioscience

Market Cap: NZ$12.9m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.038

15.2%

-17.4%